Menu Search
Equities

Know Labs Inc

KNW:ASQ

Know Labs Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.2744
  • Today's Change-0.006 / -2.00%
  • Shares traded689.23k
  • 1 Year change-43.43%
  • Beta1.5283
Data delayed at least 15 minutes, as of Sep 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Know Labs Inc had revenues fall -100.00% from 4.36m to 0.00, though the company grew net income from a loss of 20.07m to a smaller loss of 15.29m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-442.53%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Know Labs Inc fell by 4.57m. Cash Flow from Financing totalled 5.86m or -- of revenues. In addition the company used 10.35m for operations while cash used for investing totalled 80.80k.
Cash flow per share-0.2171
Price/Cash flow per share--
Book value per share-0.0533
Tangible book value per share-0.0533
More ▼

Balance sheet in USDView more

Know Labs Inc appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.27% of the market capitalization can be attributed to its 8.02m and debt could be paid in full if management chose.
Current ratio0.3482
Quick ratio--
Total debt/total equity--
Total debt/total capital6.21
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.